Podium Power

Who is the best eye doctor in Zurich? In Switzerland? In the world? While such questions are inherently subjective, peer recognition provides a meaningful benchmark. Medical trade journal, The Ophthalmologist seeks to answer this by publishing its biennial Power List—a global selection of the 100 most influential individuals shaping the future of ophthalmology.
At the WCC 2025 congress in Washington, DC, Dr. Emilio A. Torres-Netto of the ELZA Institute presented groundbreaking research on ELZA-PACE-CXL, ELZA-sub400 CXL, and Femto-CAIRS, pushing the boundaries of keratoconus treatment.
ELZA-PACE combines epi-on cross-linking with customized PTK for keratoconus without stromal tissue removal – as reported by Ocular Surgery News
At the ESCRS Winter Meeting 2025, Prof. Farhad Hafezi and Dr. Emilio Torres-Netto presented research on corneal cross-linking (CXL), including high-fluence protocols, keratoconus management, and biomechanical assessments.
During Swiss Days 2024 in Tashkent, the ELZA Institute’s CEO, Nikki L. Hafezi, led a keratoconus screening initiative that identified critical cases and strengthened Swiss-Uzbek collaborations. The event, featured on Zo’r TV, highlights ELZA’s global healthcare impact.
Central Asian University (CAU) recently hosted a highly anticipated guest lecture on “Enterprising Ophthalmology,” featuring ELZA’s CEO and CMO, Nikki and Farhad Hafezi.
Dr. Emilio Torres-Netto of the ELZA Institute was awarded the AAO Achievement Award at the 2024 Annual Meeting in Chicago, recognizing his contributions to ophthalmology through education, research, and service.
Monday, September 9 is the last day of the ESCRS 2024 meeting of the European Society of Cataract and Refractive Surgeons.
.
.